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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARYNo methods for isolating induced alveolar epithelial progenitor cells (AEPCs) from human embryonic stem cells (hESCs) and induced
pluripotent stem cells (hiPSCs) have been reported. Based on a study of the stepwise induction of alveolar epithelial cells (AECs), we iden-
tified carboxypeptidase M (CPM) as a surface marker of NKX2-1+ ‘‘ventralized’’ anterior foregut endoderm cells (VAFECs) in vitro and in
fetal human andmurine lungs. Using SFTPC-GFP reporter hPSCs and a 3D coculture systemwith fetal human lung fibroblasts, we showed
that CPM+ cells isolated from VAFECs differentiate into AECs, demonstrating that CPM is a marker of AEPCs. Moreover, 3D coculture
differentiation of CPM+ cells formed spheroids with lamellar-body-like structures and an increased expression of surfactant proteins
comparedwith 2D differentiation.Methods to induce and isolate AEPCs using CPM and consequently generate alveolar epithelial spher-
oids would aid human pulmonary disease modeling and regenerative medicine.INTRODUCTION
Type II alveolar epithelial cells (AECs) are a major cellular
component of the distal lung epithelium, where they
secrete pulmonary surfactant and generate type I AECs
that cover most of the surface area of the alveoli (Whitsett
et al., 2010; Rock and Hogan, 2011). The stepwise differen-
tiation of human pluripotent stem cells (hPSCs), including
human embryonic stem cells (hESCs) and induced pluripo-
tent stemcells (hiPSCs), into lungepithelial cellswouldhelp
to elucidate the etiologiesofhuman lungdiseases andcreate
novel treatments, and has been reported in both proximal
airway cells (Mou et al., 2012; Wong et al., 2012; Firth
et al., 2014) and distal lung epithelial cells (Green et al.,
2011; Ghaedi et al., 2013; Huang et al., 2014). Currently,
however, there are no surface markers that can be used
to purify human NKX2-1+ ‘‘ventralized’’ anterior foregut
endoderm cells (VAFECs) as alveolar epithelial progenitor
cells (AEPCs), although NKX2-1 is an early marker of lung
and thyroid development (Kimura et al., 1996). Here, we
report the efficacy of carboxypeptidaseM (CPM) as a surface
marker of AEPCs for generating type II AECs.
RESULTS
Identification of CPM as a Marker of NKX2-1+ VAFECs
We hypothesized that identifying a surface marker for
NKX2-1+ VAFECs would be helpful for isolating a ho-394 Stem Cell Reports j Vol. 3 j 394–403 j September 9, 2014 j ª2014 The Amogeneous population of AEPCs without establishing
NKX2-1 reporter cell lines. We constructed a stepwise pro-
tocol to induce hPSCs to AECs (Figure 1A). On day 0, pre-
viously established hPSCs were seeded (Thomson et al.,
1998; Takahashi et al., 2007; Nakagawa et al., 2008; Okita
et al., 2013) following single-cell enzymatic dissociation
(Kajiwara et al., 2012), resulting in definitive endodermal
cells (DECs) at an efficiency of R80% (Figure S1A avail-
able online). In step 2, the DECs were differentiated to
anterior foregut endodermal cells (AFECs) (Green et al.,
2011) at an efficiency of R88% (Figure S1B). In step 3,
the concentrations of all-trans retinoic acid, CHIR99021,
and BMP4 were optimized for seven hPSC lines for
differentiation into NKX2-1+FOXA2+ cells, attaining an
efficiency of 57.0%–77.5% (Figures 1C and 1D; Supple-
mental Experimental Procedures). In step 4, cells were
cultured in medium containing FGF10 for 7 days. In
step 5, the cells were differentiated in medium contain-
ing dexamethasone, 8-Br-cAMP, 3-isobutyl-1-methylxan-
thine, and KGF (Gonzales et al., 2002; Longmire et al.,
2012). We confirmed induction of AECs by detecting
SFTPB and SFTPC using RT-PCR and double staining
SFTPC and SFTPB with NKX2-1 (Figures S1C and S1D).
Transcription factors were analyzed by quantitative
RT-PCR (qRT-PCR; Figure 1B). SOX17, FOXA2, GATA6,
and SOX2 were compatibly changed on day 6 and
day 10 as previously described (Green et al., 2011). On
day 14, NKX2-1, GATA6, ID2, SOX9, and HOPX levelsuthors
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and HOPX levels decreased on day 21 and then increased
again on day 25. The levels of other organ lineage
markers were found to be limited from day 0 to day 25
(Figure S1E).
In order to identify candidate markers of VAFECs, we
performed a microarray analysis to compare the global
gene-expression patterns of AFECs (day 10) and VAFECs
(day 14) in 201B7 hiPSCs. CPM and NKX2-1 were remark-
ably upregulated on day 14 (Figures 1E and S1F). In immu-
nofluorescence (IF) staining, CPM and NKX2-1 increased
from day 10 to day 14 (Figure 1F), whereas EPCAM and
FOXA2 did not appear to change (Figure S1G). Although
CPM was reported to be a marker of type I AECs (Nagae
et al., 1993), only CPM drastically increased on day 14
in a similar pattern to NKX2-1, in contrast to other
markers of type I AECs (AQP5 and CAV1) (Figure S1H).
On day 25, the various airway markers, including distal
lung transcription factors (SOX9 and NKX2-1), type II
AEC markers (SFTPB and SFTPC), and a club cell marker
(SCGB3A2), were expressed in the CPM+ cells. KRT5, a
marker of basal cells, was not expressed in the CPM+ cells
(Figure 1G).
In fetal human lung at 18.5 weeks of gestation, SFTPC
and T1a were expressed separately (Figure S1I), while
CPM was expressed in NKX2-1+, SFTPC+, and T1a+ cells
(Figure 1H), thus indicating that CPM is expressed in
both type I and II AECs in the fetus. The sequential expres-
sion of CPM was confirmed in NKX2-1+ cells of fetal
murine lungs at embryonic day 12.5 (E12.5), E15.5, and
E17.5 (Figure 1I). For thyroid lineage cells, which differen-
tiated from NKX2-1+ VAFECs, CPM was found to be nega-
tive in both NKX2-1+ cells and PAX8+ epithelial cells, but
weakly positive in PECAM+ endothelial cells in the adult
human samples (Figure S1J). In E17.5 fetal and adult
murine thyroids, CPM was also negative in NKX2-1+ and
PAX8+ cells (Figure S1K), suggesting that CPM is a lung-
lineage marker of VAFECs.
Isolation of NKX2-1+ VAFECs Using Anti-CPM+
Antibody
As CPM is a membrane-bound surface protein, we per-
formed flow cytometry with anti-EPCAM and anti-CPM
antibodies after dissociating VAFECs on day 14 (Fig-
ures 2A and S2A). We then sorted EPCAM+CPM+ and
EPCAM+CPM cells and examined the global gene-expres-
sion patterns of these two populations using microarrays.
We screened 560 probes with a false discovery rate (FDR)-
adjusted p value of <0.05 among 54,675 probes. Gene clus-
tering was performed in 336 probes that differed between
the EPCAM+CPM+ and EPCAM+CPM cells with a fold
change (FC) cutoff value of 2.0 (Figures 2B and S2B). Of
the clustered genes with the highest expression in theStem CellEPCAM+CPM+ cells, CPM ranked among the top five
probes with a log FC of >6, as expected. Importantly, the
log FCs of two probes for NKX2-1 were 4.89 and 4.82,
respectively. FOXA1, FOXA2, HOPX, and GATA6 were
also included in the list of upregulated genes with log
FCs of 3.79, 3.06, 3.61, and 3.29, respectively. Next we
sorted the CPM+ cells using a magnet-activated cell
sorting (MACS) system to increase the yield, as almost all
of the CPM+ cells were EPCAM+ cells (96.7% ± 2.1% of
CPM+ cells; Figure 2A). After MACS-based sorting, the pro-
portion of CPM+ cells in three populations (presorting,
positive selection, and negative selection) was 63.4% ±
5.8%, 98.8% ± 0.4%, and 34.0% ± 7.8%, respectively, by
flow cytometry (Figure 2C). We then evaluated the propor-
tion of positive NKX2-1+ cells among the MACS-sorted
CPM+ and CPM cells using IF staining (93.0% ± 1.0%
versus 29.0% ± 1.0%; Figure S2C) and flow cytometry
(92.3% ± 0.7% versus 22.2% ± 2.3%; Figure S2D). Because
a portion of the CPM+ cells appeared to be sorted accord-
ing to MACS-based CPM negative selection, we investi-
gated the average proportion of NKX2-1+ cells among
the fluorescence-activated cell sorting (FACS)-sorted
CPM+ and CPM cells using IF staining (89.9% ± 0.4%
versus 4.5% ± 1.7%; Figure 2D). Following CPM-based pu-
rification on day 14, CPM increased significantly from
0.74-fold ± 0.12-fold to 4.94-fold ± 0.51-fold of that
observed in the fetal human lung (n = 5), while NKX2-1
increased from 0.41-fold ± 0.10-fold to 1.95-fold ± 0.36-
fold (n = 5) on qRT-PCR (Figure 2E). We then applied
this method to purify AECs on day 25. CPM, NKX2-1,
SFTPA2, SFTPB, SFTPC, DCLAMP, SCGB1A1, and SCGB3A2
were significantly increased in the CPM+ cells (n = 5); how-
ever, the level of SFTPC was extremely low compared with
that observed in the fetal lung. NGFR, a marker of prox-
imal airway basal stem cells (Rock et al., 2009), was signif-
icantly decreased in the CPM+ cells (n = 5; Figure 2F).
Generation of SFTPC-GFP Knockin Reporter hPSCs
In order to investigate whether CPM is a potential surface
marker of AEPCs, we generated SFTPC-GFP knockin re-
porter hPSC lines from 201B7 hiPSCs using BAC-based
homologous recombinationmethods (Mae et al., 2013; Fig-
ure 3A; Supplemental Experimental Procedures), as SFTPC
is the most specific marker of type II AECs. Following elec-
troporation of the targeting vectors, 12 of 55 G418-resis-
tant clones were found to have a heterozygous deletion
of the genomic endogenous SFTPC-coding region (Fig-
ure 3B). The pgk-Neo cassette was removed via electropora-
tion of the Cre-expression vector (Figure 3C), and normal
karyotypes of the A17-14 and B2-3 clones were confirmed
(Figure S3). The genomic copy number was calculated as
previously described (Mae et al., 2013). The parental
201B7 (data not shown), A17-14, and B2-3 clones haveReports j Vol. 3 j 394–403 j September 9, 2014 j ª2014 The Authors 395
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Alveolar Spheroids from Pluripotent Cellstwo copies of the SFTPC gene loci, in contrast to the A17-13
clone, in which random transgenic integration is supposed
to have occurred, as indicated by three copies of the loci
(Figure 3D). No copy-number variation was detected for
the B2-3 clone, whereas a copy-number loss at chromo-
some 16 q23.3 and gain at chromosome 20 p13 were de-
tected for the A17-14 clone (data not shown). Both
SFTPC-GFP reporter hPSCs were then differentiated to the
end of step 5 and GFP+ and GFP cells were obtained by
FACS after the CPM+ cells were sorted using MACS (Fig-
ure 3E). We confirmed the correlation between GFP and
SFTPC on RT-PCR (Figure 3F). GFP was detected in SFTPC+,
SFTPB+, and NKX2-1+ cells for both clones (Figure 3G).
Alveolar Differentiation from CPM+ VAFECs in
3D Coculture
We attempted 2D differentiation, reseeding the CPM+
SFTPC-GFP reporter hPSCs purified from VAFECs on day
14 onto Matrigel-coated, 96-well plates. After 14 days of
differentiation in step 5 medium, SFTPB became positive
in the reseeded CPM+ cells (Figure S2E); however, SFTPC
was almost negative (Figure S4D, condition b). We ob-
tained similar results when we sorted and reseeded
CPM+ cells on day 23 (Figure S2F). The discrepancy be-
tween the expression of SFTPB and SFTPC in developing
human lungs was previously reported (Khoor et al.,
1994). Therefore, we hypothesized that some missing fac-
tors are important for the coexpression of SFTPB and
SFTPC. We then adopted a 3D coculture with fetal human
lung fibroblasts (FHLFs) obtained at 17.5 weeks of gesta-
tion (Figure 4A). CPM+ cells purified from VAFECs on
day 14 and FHLFs were mixed at a ratio of 1:50 and re-
seeded onto cell inserts. After 10 days of differentiation
in step 5 medium, GFP became positive in some spheroids
(Figure 4B). The spheroids were subsequently examined
with a transmission electron microscope and lamellar-
body-like structures were noted (Figure 4C). On hematox-
ylin-and-eosin staining, cyst-like spheroids consisting ofFigure 1. Identification of CPM as a Candidate Marker of NKX2-1
(A) Stepwise differentiation to AECs from hPSCs.
(B) Gene-expression levels of transcription factors from day 0 to day
relative expression level was scored with the maximum value set to 1
(C) Induction efficiency of VAFECs analyzed by scoring the number of F
average of ten randomly selected images (n = 3).
(D) FOXA2+NKX2-1+ VAFECs derived from 201B7 hiPSCs.
(E) Scatterplots comparing the global gene-expression profiles of
(arrowheads) are noted. The lines beside the diagonal line indicate a
(F) Simultaneous increases of CPM and NKX2-1 detected by IF stainin
(G) CPM detected in NKX2-1+, SOX9+, SFTPB+, SFTPC+, and SCGB3A2+
(H) CPM detected in NKX2-1+ lung epithelial cells in fetal human lun
(I) CPM in E12.5, E15.5, and E17.5 murine lungs.
Error bars show SEM. Scale bars, 100 mm. See also Figure S1 and Tabl
Stem Cellpseudostratified, columnar, or cuboidal cells with dark
pink cytoplasm were observed in the CPM+ cell-derived
spheroids, whereas small pieces of spheroids consisting
of cuboidal cells with clear cytoplasm were noted in the
CPM cell-derived spheroids (Figure S4A). On IF staining,
CPM and NKX2-1 were double positive in most CPM+ cell-
derived spheroids, while GFP and SFTPC were double
positive in some spheroids (Figure 4D). In the CPM
cell-derived spheroids, EPCAM was positive, whereas no
CPM+ or NKX2-1+ cells were identified (Figure S4B).
SFTPA, SFTPB, SFTPC, and SFTPD (representative markers
of type II AECs) were positive in the CPM+ cell-derived
spheroids (Figure S4C). AQP5+ cells were adjacent to
SFTPC+ cells in some spheroids (Figure 4D). ID2 and
SOX9 (markers of differentiation into the distal lung-line-
age fate) were positive in some NKX2-1+ and CPM+ cells,
respectively (Figure S4C). Next, we trypsinized the cells
in 3D structures and determined the proportion of
SFTPC-GFP+ cells, detecting 3.82% ± 0.50% cells obtained
from the CPM+ cell-derived 3D structures and 0.29% ±
0.03% cells obtained from the CPM cell-derived struc-
tures including fibroblasts (Figure 4E). Excluding the
fibroblasts, the ratio of the number of SFTPC-GFP+ cells
to that of EPCAM+ cells was calculated to be 9.81% ±
1.81% in the CPM+ cell-derived spheroids and 1.07% ±
0.16% in the CPM cell-derived spheroids. Almost all of
the GFP+ cells sorted by FACS were SFTPC+, whereas the
GFP cells were SFTPC (Figure 4F). The levels of alveolar
markers (SFTPB and SFTPC), rather than club cell markers
(SCGB1A1 and SCGB3A2), were significantly elevated
following the 3D coculture differentiation of CPM+ cells
derived from three hPSC lines (H9 hESCs and parental
201B7 and 604A1 hiPSCs) compared with the 2D differen-
tiation employing the three protocols separately starting
on day 14 (Figure 1A; Green et al., 2011; Longmire
et al., 2012) and the 3D coculture differentiation of
CPM cells (Figure 4G). Interestingly, the levels of SFTPB
and SFTPC were quite low for 585A1 hiPSCs, suggesting+ VAFECs
25 (n = 3). Each value was normalized to the level of b-ACTIN. The
.0.
OXA2+ and NKX2-1+ cells relative to the total number of nuclei in an
AFECs (day 10) and VAFECs (day 14). CPM (arrows) and NKX2-1
2-fold cutoff change between the AFECs and VAFECs.
g of AFECs (day 10) and VAFECs (day 14).
cells, but not in KRT5+ cells, on day 25.
g.
es S1 and S2.
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Figure 2. Isolation of CPM+ VAFECs Using Anti-CPM Antibody
(A) Flow cytometry of VAFECs. EPCAM+CPM+ (Q2) and EPCAM+CPM cells (Q4) were isolated on day 14 (n = 3).
(B) Hierarchical clustering heatmaps of 336 genes with differences of >2-fold (FDR-adjusted p < 0.05) comparing EPCAM+CPM+ cells with
EPCAM+CPM cells. The cluster of genes increased as the greatest fold change was magnified.
(C) Flow cytometry of MACS-sorted CPM+ and CPM cells from VAFECs (n = 3).
(D) NKX2-1+ cells in FACS-sorted CPM+ and CPM cells derived from VAFECs analyzed by scoring the number of NKX2-1+ cells relative to the
total number of nuclei in an average of five randomly selected images (n = 3).
(legend continued on next page)
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Figure 3. Generation of SFTPC-GFP
Knockin hPSC Lines
(A) Strategy for BAC-based gene targeting to
produce SFTPC-GFP knockin hPSC lines.
(B) Screening of knockin hPSC lines using
TaqMan qPCR. Positive clones with candidate
heterozygous deletion of the endogenous
SFTPC gene are shown in white bars. Only
clones that were initially suspected to be
positive were tested independently three
times.
(C) Genomic PCR to confirm the removal of
the pgk-NeoR cassette by Cre-recombinase in
the A17-14 and B2-3 SFTPC-GFP reporter
hPSCs.
(D) SNP array analysis of the SFTPC-GFP
knockin hPSC lines. The copy number of
SFTPC gene loci was analyzed in A17-13,
A17-14, and B2-3 clones. The A17-14 and
B2-3 clones have two copies of the SFTPC
gene loci, whereas the A17-13 clone has
three copies of the loci. The red dots and y
axis represent the normalized signal in-
tensity of each SNP.
(E) Isolation of SFTPCGFP+ and GFP cells
via FACS after sorting CPM+ cells via MACS on
day 25.
(F) RT-PCR analyses of GFP+ and GFP sorted
cells in the A17-14 and B2-3 SFTPC-GFP re-
porter hPSC lines.
(G) Representative images of GFP detected
in SFTPC+, SFTPB+, and NKX2-1+ cells.
Error bars show SEM. Scale bars, 100 mm. See
also Figure S3 and Tables S1 and S2.
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NKX2-1+ VAFECs in step 3 is less important for subse-
quent differentiation into AECs than the difference in
the cell lines or donors. Moreover, the expression of SFTPB
and SFTPC was small for the 2D and 3D differentiation of
CPM+ cells alone or FHLFs alone (Figure S4D). Finally,
other cell-type markers (AQP5 [type I AECs], FOXJ1 [cili-(E) Levels of CPM and NKX2-1 on day 14 before and after MACS-based
(F) Levels of AEC and club-cell markers and NGFR, a proximal airway ste
CPM+ cells (n = 5).
The gene-expression level observed in the fetal lungs was set at on
#p < 0.05, *p < 0.01. Scale bars, 100 mm. See also Figure S2 and Tab
Stem Cellated cells], and AGR2 [goblet cells]) appeared to be
elevated in the CPM+ cell-derived structures rather than
in the CPM cell-derived structures, suggesting that cell-
type markers other than club-cell markers were expressed
in the CPM+ cell-derived spheroids. KRT5 (a basal cell
marker, possibly including both airway and esophageal
basal cells) was exclusively expressed in the CPMpurification of CPM+ cells on qRT-PCR (n = 5).
m cell marker, on day 25 before and after MACS-based purification of
e. Values are presented as the mean ± SEM. Error bars show SEM.
les S1 and S2.
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Figure 4. Alveolar Differentiation from CPM+ VAFECs in 3D Coculture
(A) Strategy for inducing AECs via 3D coculture with FHLFs.
(B) SFTPC-GFP+ cells detected in spheroids derived from isolated CPM+ VAFECs.
(C) Transmission electron microscopy of lamellar-body-like structures observed in 3D coculture differentiation of CPM+ cells compared with
those observed in the adult and fetal murine lungs. Lu, lumen.
(D) IF staining of spheroids derived from CPM+ VAFECs.
(E) Flow cytometry of SFTPC-GFP+ cells in 3D coculture differentiation of CPM+ cells or CPM cells (n = 3).
(F) GFP+ and GFP cells isolated via FACS, spun down onto slides, and stained by anti-GFP and anti-SFTPC antibodies.
(legend continued on next page)
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marker), PAX6 (a neuron marker), and the other foregut
endodermal lineage cells (FOXN1, ALB, and PDX1) were
only minimally or slightly induced following 3D cocul-
ture differentiation (Figure S4E).DISCUSSION
In this work, we identified CPM as a surface marker
that is expressed in NKX2-1+ VAFECs, including AEPCs,
and demonstrated that the CPM+ cell-derived spheroids
obtained via 3D coculture differentiation with FHLFs
enabled more efficient differentiation to AECs than did
2D differentiation. The gene-expression pattern of CPM
in developing lungs has not received significant attention,
although in situ hybridization of Cpm in anterior DECs as
early as E7.5 in mice has been reported (Tamplin et al.,
2008). Our data from IF staining of murine fetal lungs (Fig-
ure S1I) also suggest that lineage-tracing studies may pro-
vide answers to the following questions: Is Cpm a possible
‘‘specific’’ marker of lung-lineage progenitor cells such as
Shh (Harris et al., 2006), Id2 (Rawlins et al., 2009a), and
Nkx2-1 (Longmire et al., 2012)? What is the relationship
between CPM+ cells and bipotent cells that are capable of
generating type I and type II AECs (Desai et al., 2014)?
Do CPM+ cells differentiate into type II AECs directly or
indirectly via SFTPC+SCGB1A1+ cells (Kim et al., 2005;
Rawlins et al., 2009b)? Furthermore, the present study sug-
gests that a 3D microenvironment and coculture with
FHLFs are important factors in the differentiation of pro-
genitor cells into AECs rather than club cells. Although
maintaining type II AECs in 2D conditions is often difficult
(Dobbs, 1990; Yu et al., 2007), 3D conditions have recently
been applied with better outcomes (Yu et al., 2007;
McQualter et al., 2010; Barkauskas et al., 2013). Therefore,
our 3D differentiation protocol appears to be a reasonable
approach for maintaining differentiated type II AECs,
although methods for expanding such cells for longer
periods should be established in the next step.
The limitations of the present study include the fact that
we were unable to demonstrate whether CPM is a more
appropriate marker for lung-lineage cells than NKX2-1.
Future studies focusing on the possible contribution of
NKX2-1CPM+ cells and/or NKX2-1+CPM cells to the dif-
ferentiation of lung epithelial cells may resolve this issue,
although we found only two isolatable populations of
NKX2-1+CPM+ and NKX2-1CPM cells using the present(G) qRT-PCR comparing the 2D and 3D differentiation into AECs in H9 h
the gene expression was normalized to the level of b-ACTIN. The leve
Values are presented as the mean ± SEM. Error bars show SEM. #p < 0.05
Figure S4 and Tables S1 and S2.
Stem Cellprotocol. In addition, we were unable to demonstrate the
highest induction efficiency of AECs, as recently described
(Ghaedi et al., 2013), although we employed a different
method for evaluating efficiency using SFTPC-GFP re-
porter hPSCs. Another limitation is that the functions of
the induced AECs remain to be elucidated.
Nevertheless, the methods applied in the present study
to induce and isolate AEPCs using CPM and consequently
generate alveolar epithelial spheroids in a stepwise fashion
may help to elucidate the complicated differentiation of
human AECs and open the door for the development of
new strategies for in vitro toxicology and cell replacement
therapy, as well as screening for therapeutic drug com-
pounds, in the future.EXPERIMENTAL PROCEDURES
2D Differentiation
CHIR99021 (Axon Medchem), an activator of canonical Wnt
signaling, was substituted forWNT3A (Mae et al., 2013). For details
regarding the protocols used for each differentiation medium, see
the Supplemental Experimental Procedures.3D Differentiation
The protocol for the 3D culture was modified from a previous
report (Barkauskas et al., 2013). For further details, see the Supple-
mental Experimental Procedures.Ethics
The use of H9 hESCs was approved by the Ministry of Education,
Culture, Sports, Science and Technology (MEXT) of Japan. Human
ethics approval was obtained from the Institutional Review Board
and Ethics Committee of Kyoto University Graduate School and
Faculty of Medicine. Animal ethics approval was obtained from
the Animal Ethics and Research Committee of Kyoto University.Statistical Analysis
Values are expressed as the mean ± SEM and ‘‘n’’ stands for the
number of independent experiments. Two-tailed Student’s t test
was performed to identify significant differences between two
conditions of qRT-PCR.ACCESSION NUMBERS
The NCBI GEO accession number for the microarray data reported
in this paper is GSE53513.ESCs and 201B7 (parental), 604A1, and 585A1 hiPSCs. Each value of
ls of the fetal lungs were set at one.
, *p < 0.01. Scale bars, 100 mm unless otherwise indicated. See also
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Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.07.005.
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